GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 327 filers reported holding GW PHARMACEUTICALS PLC in Q2 2019. The put-call ratio across all filers is 1.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $126,350,000 | -3.6% | 749,538 | -44.3% | 4.67% | +5.0% |
| Q4 2018 | $131,009,000 | -49.0% | 1,345,198 | -9.6% | 4.44% | -10.1% |
| Q3 2018 | $256,917,000 | -9.7% | 1,487,307 | -27.0% | 4.94% | -0.5% |
| Q2 2018 | $284,400,000 | -7.0% | 2,038,125 | -24.9% | 4.97% | -18.8% |
| Q1 2018 | $305,920,000 | -32.9% | 2,715,187 | -21.4% | 6.12% | -25.2% |
| Q4 2017 | $456,102,000 | +50.4% | 3,455,054 | +15.6% | 8.18% | +70.6% |
| Q3 2017 | $303,254,000 | +21.3% | 2,988,019 | +19.8% | 4.80% | -7.1% |
| Q2 2017 | $250,097,000 | +4.0% | 2,494,738 | +25.5% | 5.16% | +16.2% |
| Q1 2017 | $240,467,000 | +3.2% | 1,988,317 | -4.6% | 4.44% | +0.6% |
| Q4 2016 | $232,950,000 | -6.9% | 2,084,567 | +10.6% | 4.41% | 0.0% |
| Q3 2016 | $250,218,000 | +84.9% | 1,885,167 | +27.6% | 4.41% | +57.9% |
| Q2 2016 | $135,314,000 | – | 1,477,709 | – | 2.79% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 86,069 | $18,668,000 | 8.69% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 170,108 | $36,897,000 | 6.84% |
| HARVEST MANAGEMENT LLC | 44,100 | $9,565,000 | 5.72% |
| Twin Securities, Inc. | 39,541 | $8,576,000 | 5.50% |
| TIG Advisors, LLC | 572,743 | $124,228,000 | 4.67% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 787,500 | $170,810,000 | 4.63% |
| First Trust Capital Management L.P. | 105,822 | $22,953,000 | 4.49% |
| Pentwater Capital Management LP | 2,102,104 | $455,946,000 | 4.35% |
| OMNI PARTNERS LLP | 403,061 | $87,424,000 | 4.31% |
| SPRING CREEK CAPITAL LLC | 370,000 | $80,253,000 | 3.47% |